Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy ☆
Titel:
Final survival results from the PENELOPE-B trial investigating palbociclib versus placebo for patients with high-risk HR+/HER2− breast cancer and residual disease after neoadjuvant chemotherapy ☆
Auteur:
Loibl, S. Martin, M. Bonnefoi, H. Untch, M. Kim, S.-B. Bear, H.D. García-Sáenz, J.A. Melé Olivé, M. Mc Carthy, N. Gelmon, K. Kelly, C.M. Im, S.-A. Reimer, T. Martinez-Janez, M. Zhang, Z. Toi, M. Provencher, L. Rugo, H.S. Gnant, M. Makris, A. Antón Torres, A. Hirmas, N. Holtschmidt, J. Nekljudova, V. Marmé, F.